1.
Garcia-Monco JC,
Martinez A,
Brochado AP,
Saralegui I,
Cabrera A,
Beldarrain MG.
Isolated and Reversible Lesions of the Corpus Callosum: A Distinct Entity.
Journal of Neuroimaging.
2010;20(1):1–2.
2.
MD AN,
MD JW,
MSc LC,
Van Coster PhD R,
MD HV.
Expanding the Spectrum of MERS Type 2 Lesions,
a Particular Form of Encephalitis.
Pediatric Neurology.
2013;48(2):135–138.
3.
Hara M,
Mizuochi T,
Kawano G,
et al.
A case of clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.
Brain and Development.
2011;33(10):842–844.
4.
Kubota T,
Kidokoro H,
Ito M,
et al.
Diffusion-weighted imaging abnormalities in the corpus callosum after neonatal seizure: A case report.
Brain and Development.
2008;30(3):215–217.
5.
Cho J-S,
Ha S-W,
Han Y-S,
et al.
Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter.
J Clin Neurol.
2007;3(1):53–56.
6.
Miyata R,
Tanuma N,
Hayashi M,
et al.
Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
Brain and Development.
2012;34(2):124–127.
7.
Masahiro Tsuji MD P,
MD TY,
MD CM,
MD TH.
Is a Reversible Splenial Lesion a Sign of Encephalopathy? Pediatric Neurology.
2009;41(2):143–145.
8.
Imamura T,
Takanashi J-I,
Yasugi J,
Terada H,
Nishimura A.
Sisters with clinically mild encephalopathy with a reversible splenial lesion (MERS)-like features; Familial MERS? Journal of the Neurological Sciences.
2010;290(1-2):153–156.
9.
Shimizu H,
Kataoka H,
Yagura H,
Hirano M,
Taoka T,
Ueno S.
Extensive neuroimaging of a transient lesion in the splenium of the corpus callosum.
European Journal of Neurology.
2007;14(1):e37–e39.